Pharmacokinetics and acute tolerance of a double virus inactivated plasma derived factor VIII concentrate
- 1 July 1999
- journal article
- clinical trial
- Published by Wiley in Haemophilia
- Vol. 5 (4) , 260-265
- https://doi.org/10.1046/j.1365-2516.1999.00290.x
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Prospective study of the evaluation of hepatitis C virus infectivity in a high‐purity, solvent/detergent‐treated factor VIII concentrate: parallel evaluation of other markers for lipid‐enveloped and non‐lipid‐ enveloped viruses.Transfusion, 1993
- Clinical Evaluation of Viral Safety of Coagulation Factor VIII and IX ConcentratesVox Sanguinis, 1993
- Acute hepatitis A in patients with haemophilia AThe Lancet, 1993
- Clotting factors and hepatitis AThe Lancet, 1992
- Acute hepatitis A in haemophiliacsThe Lancet, 1992
- Outbreak of hepatitis A among Italian patients with haemophiliaThe Lancet, 1992
- Low risk of transmission of the human immunodeficiency virus by a solvent‐detergent‐treated commercial factor VIII concentrateJournal of Medical Virology, 1992
- Hepatitis C virus seroprevalence in Italian haemophiliacs injected with virus‐inactivated concentrates: Five year follow‐up and correlation with antibodies to other virusesJournal of Medical Virology, 1991
- Tri(n‐Butyl) Phosphate/Detergent Treatment of Licensed Therapeutic and Experimental Blood Derivatives1Vox Sanguinis, 1987
- Calculations of Factor VIII in vivo Recovery and Half‐lifeScandinavian Journal of Haematology, 1984